These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34405610)

  • 1. [Whole exome sequencing reveals molecular mechanisms of clear cell renal cell carcinoma with sarcomatoid differentiation].
    Yu WJ; Jiang YX; Zhang W; Li GQ; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2021 Jul; 50(7):756-761. PubMed ID: 34405610
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel highly frequent single‑nucleotide polymorphism site of cadherin 23 in clear cell renal cell carcinoma with sarcomatoid differentiation based on whole exome sequencing.
    Yu W; Wang X; Wang Y; Jiang Y; Zhang W; Shi H; Li Y
    Oncol Rep; 2020 Aug; 44(2):735-746. PubMed ID: 32468012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma.
    Bi M; Zhao S; Said JW; Merino MJ; Adeniran AJ; Xie Z; Nawaf CB; Choi J; Belldegrun AS; Pantuck AJ; Kluger HM; Bilgüvar K; Lifton RP; Shuch B
    Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2170-5. PubMed ID: 26864202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-grade spindle cell proliferation in clear cell renal cell carcinoma is unlikely to be an initial step in sarcomatoid differentiation.
    Tanas Isikci O; He H; Grossmann P; Alaghehbandan R; Ulamec M; Michalova K; Pivovarcikova K; Montiel DP; Ondic O; Daum O; Prochazkova K; Hora M; Michal M; Hes O
    Histopathology; 2018 Apr; 72(5):804-813. PubMed ID: 29194709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic Alterations.
    Malouf GG; Ali SM; Wang K; Balasubramanian S; Ross JS; Miller VA; Stephens PJ; Khayat D; Pal SK; Su X; Sircar K; Tamboli P; Jonasch E; Tannir NM; Wood CG; Karam JA
    Eur Urol; 2016 Aug; 70(2):348-57. PubMed ID: 26895810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of CDH23 mutations in Korean families with hearing loss by whole-exome sequencing.
    Woo HM; Park HJ; Park MH; Kim BY; Shin JW; Yoo WG; Koo SK
    BMC Med Genet; 2014 Apr; 15():46. PubMed ID: 24767429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of CD44, matrix metalloproteinase2 and matrix metalloproteinase9 in renal cell carcinomas.
    Lee YM; Kim JM; Lee HJ; Seong IO; Kim KH
    Urol Oncol; 2019 Oct; 37(10):742-748. PubMed ID: 31053527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Novel
    Ramzan K; Al-Numair NS; Al-Ageel S; Elbaik L; Sakati N; Al-Hazzaa SAF; Al-Owain M; Imtiaz F
    Genes (Basel); 2020 Dec; 11(12):. PubMed ID: 33316915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational heterogeneity between different regional tumour grades of clear cell renal cell carcinoma.
    Ferronika P; Kats-Ugurlu G; Haryana SM; Utoro T; Rinonce HT; Danarto R; de Lange K; Terpstra MM; Sijmons RH; Westers H; Kok K
    Exp Mol Pathol; 2020 Aug; 115():104431. PubMed ID: 32259515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined mutation in Vhl, Trp53 and Rb1 causes clear cell renal cell carcinoma in mice.
    Harlander S; Schönenberger D; Toussaint NC; Prummer M; Catalano A; Brandt L; Moch H; Wild PJ; Frew IJ
    Nat Med; 2017 Jul; 23(7):869-877. PubMed ID: 28553932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of TNF-α and CD44 is implicated in poor prognosis, cancer cell invasion, metastasis and resistance to the sunitinib treatment in clear cell renal cell carcinomas.
    Mikami S; Mizuno R; Kosaka T; Saya H; Oya M; Okada Y
    Int J Cancer; 2015 Apr; 136(7):1504-14. PubMed ID: 25123505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Programmed cell death ligand 1 and tumor-infiltrating lymphocyte status in patients with renal cell carcinoma and sarcomatoid dedifferentiation.
    Kawakami F; Sircar K; Rodriguez-Canales J; Fellman BM; Urbauer DL; Tamboli P; Tannir NM; Jonasch E; Wistuba II; Wood CG; Karam JA
    Cancer; 2017 Dec; 123(24):4823-4831. PubMed ID: 28832979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXC2 and CLIP4 : a potential biomarker for synchronous metastasis of ≤7-cm clear cell renal cell carcinomas.
    Ahn J; Han KS; Heo JH; Bang D; Kang YH; Jin HA; Hong SJ; Lee JH; Ham WS
    Oncotarget; 2016 Aug; 7(32):51423-51434. PubMed ID: 27283491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations of the p53 gene and p53 protein overexpression are associated with sarcomatoid transformation in renal cell carcinomas.
    Oda H; Nakatsuru Y; Ishikawa T
    Cancer Res; 1995 Feb; 55(3):658-62. PubMed ID: 7834636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased expression of dual-specificity phosphatase 9 is associated with poor prognosis in clear cell renal cell carcinoma.
    Wu S; Wang Y; Sun L; Zhang Z; Jiang Z; Qin Z; Han H; Liu Z; Li X; Tang A; Gui Y; Cai Z; Zhou F
    BMC Cancer; 2011 Sep; 11():413. PubMed ID: 21943117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness.
    Li Y; Lih TM; Dhanasekaran SM; Mannan R; Chen L; Cieslik M; Wu Y; Lu RJ; Clark DJ; Kołodziejczak I; Hong R; Chen S; Zhao Y; Chugh S; Caravan W; Naser Al Deen N; Hosseini N; Newton CJ; Krug K; Xu Y; Cho KC; Hu Y; Zhang Y; Kumar-Sinha C; Ma W; Calinawan A; Wyczalkowski MA; Wendl MC; Wang Y; Guo S; Zhang C; Le A; Dagar A; Hopkins A; Cho H; Leprevost FDV; Jing X; Teo GC; Liu W; Reimers MA; Pachynski R; Lazar AJ; Chinnaiyan AM; Van Tine BA; Zhang B; Rodland KD; Getz G; Mani DR; Wang P; Chen F; Hostetter G; Thiagarajan M; Linehan WM; Fenyö D; Jewell SD; Omenn GS; Mehra R; Wiznerowicz M; Robles AI; Mesri M; Hiltke T; An E; Rodriguez H; Chan DW; Ricketts CJ; Nesvizhskii AI; Zhang H; Ding L;
    Cancer Cell; 2023 Jan; 41(1):139-163.e17. PubMed ID: 36563681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline Mutations in CDH23, Encoding Cadherin-Related 23, Are Associated with Both Familial and Sporadic Pituitary Adenomas.
    Zhang Q; Peng C; Song J; Zhang Y; Chen J; Song Z; Shou X; Ma Z; Peng H; Jian X; He W; Ye Z; Li Z; Wang Y; Ye H; Zhang Z; Shen M; Tang F; Chen H; Shi Z; Chen C; Chen Z; Shen Y; Wang Y; Lu S; Zhang J; Li Y; Li S; Mao Y; Zhou L; Yan H; Shi Y; Huang C; Zhao Y
    Am J Hum Genet; 2017 May; 100(5):817-823. PubMed ID: 28413019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SWI/SNF chromatin-remodeling complex status in renal cell carcinomas with sarcomatoid or rhabdoid features.
    Kinoshita F; Kohashi K; Sugimoto M; Takamatsu D; Kiyozawa D; Eto M; Oda Y
    Virchows Arch; 2020 Nov; 477(5):651-660. PubMed ID: 32447490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating exosomal mRNA signatures for the early diagnosis of clear cell renal cell carcinoma.
    He X; Tian F; Guo F; Zhang F; Zhang H; Ji J; Zhao L; He J; Xiao Y; Li L; Wei C; Huang C; Li Y; Zhang F; Yang B; Ye H; Wang F
    BMC Med; 2022 Aug; 20(1):270. PubMed ID: 36002886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratumoral heterogeneity in kidney cancer.
    Ricketts CJ; Linehan WM
    Nat Genet; 2014 Mar; 46(3):214-5. PubMed ID: 24569233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.